Key result
Substance use in women links to ~10% higher sST2, a biomarker of adverse cardiac remodeling.
Why the study?
Cardiac biomarker research rarely evaluates controlled substances, which may influence biomarker levels and CVD risk assessment.
Does multiple substance use influence circulating sST2 levels in low-income women?
Observational (n=245)
Does multiple substance use influence circulating sST2 levels in low-income women?
Multiple substance use, including cocaine, alcohol, and heroin, is associated with elevated levels of the cardiac remodeling biomarker sST2 in low-income women, suggesting substance use should be considered in cardiovascular risk assessment.
Answers are grounded in this paper and cite their sources.
Substance use may confound sST2 interpretation in women; leaves open causal effects on remodeling.
CONTEXT: Cardiovascular disease (CVD) and heart failure (HF) are major causes of mortality in low-income populations and differ by sex. Risk assessment that incorporates cardiac biomarkers is common. However, research evaluating the utility of biomarkers rarely includes controlled substances, which may influence biomarker levels and thus influence CVD risk assessment. MATERIALS AND METHODS: We identified the effects of multiple substances on soluble "suppression of tumorigenicity 2" (sST2), a biomarker of adverse cardiac remodelling, in 245 low-income women. Adjusting for CVD risk factors, we examined associations between substance use and sST2 over six monthly visits. RESULTS: Median age was 53 years and 74% of participants were ethnic minority women. An sST2 level > 35 ng/mL (suggesting cardiac remodelling) during ≥1 study visit was observed in 44% of participants. In adjusted analysis, higher sST2 levels were significantly and positively associated with the presence of cocaine (Adjusted Linear Effect [ALE]:1.10; 95% CI:1.03-1.19), alcohol (ALE:1.10; 95% CI:1.04-1.17), heroin (ALE:1.25; 95% CI:1.10-1.43), and the interaction between heroin and fentanyl use. CONCLUSION: Results suggest that the use of multiple substances influences the level of sST2, a biomarker often used to evaluate cardiovascular risk. Incorporating substance use alongside cardiac biomarkers may improve CVD risk assessment in vulnerable women.
No takes yet. Share an insight, caveat, or question.
Riley et al. (2022) conducted an observational in Cardiovascular disease risk assessment (n=245). Substance use (cocaine, alcohol, heroin, fentanyl) was evaluated on soluble suppression of tumorigenicity 2 (sST2) levels (ALE 1.10, 95% CI 1.03-1.19). Substance use, including cocaine, alcohol, and heroin, was associated with higher levels of sST2, a biomarker of adverse cardiac remodelling, in women.
Synapse has enriched 10 related papers. Consider them for comparative context: